Cost-effectiveness analysis of a pharmacy asthma care program in Australia

Disease Management and Health Outcomes

Volumn 15, Issue 6, 2007, Pages 387-396

  Gordois, Adam ^a   Armour, Carol ^b   Brillant, Martha ^b   Bosnic Anticevich, Sinthia ^b   Burton, Deborah ^c   Emmerton, Lynne ^d   Krass, Ines ^b   Saini, Bandana ^b   Smith, Lorraine ^b   Stewart, Kay ^e  

^a IQVIA   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CHARLES STURT UNIVERSITY   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

Asthma, treatment; Cost utility; Pharmaceutical care programmes

Indexed keywords

SALBUTAMOL;

ARTICLE; ASTHMA; AUSTRALIA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG COST; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; PHARMACEUTICAL CARE; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE;

EID: 36949011413     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200715060-00006     Document Type: Article

References (22)

1. Australian Bureau of Statistics. National health survey: summary of results, 2004-2005. Catalogue no. 4364.0. Canberra (ACT): Australian Bureau of Statistics, 2006
2. Australian Institute of Health and Welfare. Australia's health. No. 9. Canberra (ACT): AIHW, 2004
3. Australian Institute of Health and Welfare. Australian Centre for Asthma Monitoring 2005: asthma in Australia 2005. AIHW Asthma Series 2, AIHW cat. no. ACM 6. Canberra (ACT): AIHW, 2005
4. Mathers CD, Vos ET, Stevenson CE, et al. The Australian Burden of Disease Study: measuring the loss of health from diseases, injuries and risk factors. Med J Aust 2000; 172: 592-6
5. Wilson DH, Adams RJ, Appleton SL, et al. Prevalence of asthma and asthma action plans in South Australia: population surveys from 1990-2001. Med J Aust 2003; 178: 483-5
6. Armour C, Bosnic-Anticevich S, Brillant M, et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax 2007; 62 (6): 496-502
7. Hawthorne G, Richardson J, Osborne R. The assessment of quality of life (AQoL) instrument: a psychometric measure of health-related quality of life. Qual Life Res 1999; 8: 209-24
8. Briggs A, Sculpher M. An introduction to Markov modeling for economic evaluation. Pharmacoeconomics 1998; 13: 397-409
9. Asthma Management Handbook. 5th ed. Melbourne: National Asthma Council of Australia, 2002 [online]. Available from URL: http://www.nationalasthma.org.au/ publications/amh/amhcont.htm [Accessed 2006 Aug 1]
10. Blumenschein K, Johannesson M. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma. Ann Allergy Asthma Immunol 1998; 80: 189-94
11. Australian Government, Department of Health and Ageing. Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee including major submissions involving economic analyses. Canberra (ACT): Australian Government, Department of Health and Ageing, 2002
12. Australian Bureau of Statistics. Life tables, Australia 2002-2004. ABS Cat. no 3302.0.55.001. Canberra (ACT): Australian Bureau of Statistics, 2004
13. Australian Government, Department of Health and Ageing. Schedule of pharmaceutical benefits from 1 December 2006. Canberra (ACT): Australian Government, Department of Health and Ageing, 2006
14. Australian Government, Department of Health and Ageing. Medicare benefits schedule effective 1 August 2006. Canberra (ACT): Australian Government, Department of Health and Ageing, 2006
15. Australian Government, Department of Health and Ageing. Public sector estimated round 9 (2004-2005) AR-DRG 4.2 cost report. Canberra (ACT): Australian Government, Department of Health and Ageing, 2006
16. Australian Government, Department of Health and Ageing. Manual of resource items and their associated costs. Canberra (ACT): Australian Government, Department of Health and Ageing, 2002
17. Australian Institute of Health and Welfare. Health expenditure Australia: 2004-2005. AIHW cat. no. HWE 35. Canberra (ACT): AIHW, 2006
18. World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2006. Oslo: Norwegian Institute of Public Health [online]. Available from URL: http://www.whocc.no/atcddd/indexdatabase/ [Accessed 2006 Jun 1]
19. George B, Harris A, Mitchell A. Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in Australia (1991 to 1996). Pharmacoeconomics 2001; 19: 1103-9
20. Saini B, Krass I, Armour C. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother 2004; 38: 1954-60
21. Nishiyama T, Chrystyn H. The Jones Morbidity Index as an aid for community pharmacists to identify poor asthma control during the dispensing process. Int J Pharm Pract 2003; 11: 41-6
22. Global Initiative for Asthma [online]. Available from URL: http://www.ginasthma.com [Accessed 2007 Oct 16]